Phibro Animal (Germany) Performance
| PB8 Stock | EUR 19.60 0.40 2.00% |
The company holds a Beta of -0.29, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Phibro Animal are expected to decrease at a much lower rate. During the bear market, Phibro Animal is likely to outperform the market. At this point, Phibro Animal Health has a negative expected return of -0.065%. Please make sure to check Phibro Animal's jensen alpha, sortino ratio, and the relationship between the information ratio and total risk alpha , to decide if Phibro Animal Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Phibro Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Phibro Animal is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 50.2 M | |
| Total Cashflows From Investing Activities | -22.6 M | |
| Free Cash Flow | -5.4 M |
Phibro |
Phibro Animal Relative Risk vs. Return Landscape
If you would invest 2,069 in Phibro Animal Health on October 11, 2024 and sell it today you would lose (109.00) from holding Phibro Animal Health or give up 5.27% of portfolio value over 90 days. Phibro Animal Health is currently producing negative expected returns and takes up 2.3474% volatility of returns over 90 trading days. Put another way, 20% of traded stocks are less volatile than Phibro, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Phibro Animal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phibro Animal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Phibro Animal Health, and traders can use it to determine the average amount a Phibro Animal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0277
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PB8 |
Estimated Market Risk
| 2.35 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Phibro Animal is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phibro Animal by adding Phibro Animal to a well-diversified portfolio.
Phibro Animal Fundamentals Growth
Phibro Stock prices reflect investors' perceptions of the future prospects and financial health of Phibro Animal, and Phibro Animal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Phibro Stock performance.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0532 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 977.72 M | |||
| Shares Outstanding | 20.34 M | |||
| Price To Earning | 21.51 X | |||
| Price To Book | 2.32 X | |||
| Price To Sales | 0.52 X | |||
| Revenue | 942.26 M | |||
| EBITDA | 117.13 M | |||
| Cash And Equivalents | 93.21 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 417.93 M | |||
| Debt To Equity | 1.80 % | |||
| Book Value Per Share | 6.63 X | |||
| Cash Flow From Operations | 31.65 M | |||
| Earnings Per Share | 0.84 X | |||
| Total Asset | 931.7 M | |||
About Phibro Animal Performance
By analyzing Phibro Animal's fundamental ratios, stakeholders can gain valuable insights into Phibro Animal's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Phibro Animal has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Phibro Animal has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey. PHIBRO ANIMAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1725 people.Things to note about Phibro Animal Health performance evaluation
Checking the ongoing alerts about Phibro Animal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Phibro Animal Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Phibro Animal Health generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors |
- Analyzing Phibro Animal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Phibro Animal's stock is overvalued or undervalued compared to its peers.
- Examining Phibro Animal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Phibro Animal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Phibro Animal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Phibro Animal's stock. These opinions can provide insight into Phibro Animal's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |